BIG
7005 S0.515
0.515
0.000 (0.0%)| High | 0.515 |
| Low | 0.515 |
| Open | 0.515 |
| Volume | 20,000 |
| Volume (B/S) | 30,000 / 3,000 |
| Price Bid/Ask | 0.515 / 0.525 |
| 52w | 0.485 - 0.675 |
| ROE | 4.41 |
| P/E | 14.60 |
| EPS | 3.53 |
| DPS | |
| DY | 0.00% |
| NTA | 0.8000 |
| P/B | 0.64 |
| RPS | 49.37 |
| PSR | 1.04 |
| Market Cap | 32.7M |
| Shares (mil) | 63.48 |
| CAGR |
3Y
4.8%
TTM
-17.6%
5Y
35.1%
TTM
25.3%
|
|
| RSI(14) | Neutral 44.2 |
| Stochastic(14) | Oversold 10.0 |
| Stochastic RSI(14) | Oversold 20.0 |
| Average Volume (3M) | 9,300 |
| Relative Volume | 3.0 |
| Financial Year | Revenue ('000) | Net ('000) | EPS | DP% | Net % | Report |
|---|---|---|---|---|---|---|
| 30 Jun, 2026 | 6,709 | 432 | 0.6800 | - | ||
| 30 Jun, 2025 | 38,395 | 4,641 | 7.3100 | - | 6.2% | View |
| 30 Jun, 2024 | 38,635 | 4,950 | 7.8000 | - | 87.8% | View |
| 30 Jun, 2023 | 37,228 | 2,636 | 4.1500 | - | 34.6% | View |
| 30 Jun, 2022 | 39,716 | 4,033 | 7.3000 | - | 2,147.2% | View |
| 30 Jun, 2021 | 31,835 | -197 | -0.3700 | - | 89.4% | View |
| 30 Jun, 2020 | 31,851 | -1,850 | -3.4300 | - | 293.7% | View |
| 30 Jun, 2019 | 45,990 | 955 | 1.9800 | - | 121.1% | View |
| 30 Jun, 2018 | 39,909 | -4,518 | -9.4000 | - | 34.1% | View |
| 30 Jun, 2017 | 43,214 | -6,858 | -14.2600 | - | 542.7% | View |
| 30 Jun, 2016 | 75,336 | 1,549 | 3.2200 | - | 401.4% | View |
| 31 Dec, 2015 | 17,924 | -514 | -1.0700 | - | ||
| 31 Dec, 2014 | 78,304 | -6,802 | -14.1300 | - | 278.3% | View |
| 31 Dec, 2013 | 92,830 | 3,814 | 7.9300 | - | 258.7% | View |
| 31 Dec, 2012 | 98,059 | -2,403 | -4.9900 | - | 61.6% | View |
| 31 Dec, 2011 | 92,891 | -6,262 | -13.0200 | - | 159.9% | View |
| 31 Dec, 2010 | 82,957 | -2,409 | -5.0100 | - | 62.1% | View |
| 31 Dec, 2009 | 84,846 | -6,348 | -13.2000 | - | 261.1% | View |
| 31 Dec, 2008 | 92,886 | 3,940 | 8.1900 | - | 988.4% | View |
| 31 Dec, 2007 | 68,471 | 362 | 0.7500 | - | 2,162.5% | View |
| 31 Dec, 2006 | 74,851 | 16 | 0.1300 | - | 99.2% | View |
| 31 Dec, 2005 | 96,043 | 1,914 | 5.2100 | - | 46.7% | View |
| 31 Dec, 2004 | 50,434 | 3,593 | 7.4700 | 0.13 | 604.5% | View |
| 31 Mar, 2004 | 15,393 | 510 | 1.3800 | - | 86.9% | View |
| 31 Dec, 2003 | 52,952 | 3,904 | 20.3200 | - | 256.9% | View |
| 31 Dec, 2002 | 24,185 | 1,094 | 5.6900 | - | View |
| Announced | Financial Year | Subject | EX Date | Payment Date | Amount | Indicator |
|---|
No dividends
| Announced | EX Date | Subject | Ratio | Offer |
|---|
No records
| Name | Price | Change | Volume | Gearing | Premium | Premium % | Maturity |
|---|
No warrants found.
Recent News
-
医疗业务上市是“跳板” 双威布局多元盈利引擎
丰隆投行指出,双威旗下的双威医疗控股上市,应被视为推动集团迈向下一阶段增长的“跳板”,而非发展终点。...Nanyang -
双威医疗上市成跳板 双威盈利增长料续强劲
(吉隆坡2日讯)双威(SUNWAY,5211,主板工业产品服务组)旗下双威医疗(Sunway Healthcare)预期在今年3月上市马股主板,分析员相信这并非终点,反而为集团提供壮大医疗臂膀,以及将上市所得资金重新部署至其他高回酬项目的跳板,强劲盈利增长动能将延续至2026财政年。丰隆研究表示,占双威2025财政年首9个月核心盈利14.8%的双威医疗预期在3月于马股主板上市,一旦上市,双威有效持股将稀释约14.5%,从现有的84%降至69.5%,但2025财政年9个月盈利仅预期减少约2.6%...Sinchew -
【2025封关】马股新秀跌多升少 华阳餐饮荣登新股王
今年大马首次公开募股(IPO)市场再创高峰,迎来60家新上市公司。...Nanyang -
2025年十大经济新闻回顾2
在区域格局、政策改革与资本市场动态交织的一年里,大马商业环境持续出现结构性变化。...Nanyang -
BIG CARiNG携手日台品牌 推动亚洲预防医疗发展
(吉隆坡2日讯)我国最大连锁药局BIG CARiNG集团宣布,与台湾领先连锁药局大树药局(Great Tree Pharmacy)以及拥有百年历史的日本健康品牌B&S Corporation建立战略合作关系。BIG CARiNG集团在文告指出,此合作标志著三方携手打造亚洲健康与保健产业多赢生态体系的重要里程碑。“BIG CARiNG拥有广泛的区域药局网络、大树药局在市场亦拥有领先实力,而B&S百年来在先进健康科研与严苛品质标准上的专业著称。”李名全...Chinapress
Recent Announcements
-
OTHERS
B.I.G. INDUSTRIES BERHAD ("THE COMPANY") PROPOSED DISPOSAL OF LAND HELD UNDER PAJAKAN NEGERI 4163 (FORMERLY KNOWN AS CL 205359495) AND PAJAKAN NEGERI 4165 (FORMERLY KNOWN AS CL 205359486) TOGETHER WITH OPEN SIDED STORAGE SHEDS AND AN OFFICE BUILDING CONSTRUCTED THEREON SITUATED AT KG DURIAN TUNJONG, OFF JALAN POHON BATU, 87000 FEDERAL TERRITORY OF LABUAN, MALAYSIA ("PROPERTY") BY B.I.G. INDUSTRIAL GAS SDN BHD [198001008612 (62396-A)] ("BIGG"), A WHOLLY-OWNED SUBSIDIARY OF THE COMPANY -
General Meetings: Outcome of Meeting
-
Quarterly rpt on consolidated results for the financial period ended 30/09/2025
-
CIRCULAR TO SHAREHOLDERS IN RELATION TO PROPOSED RENEWAL OF SHAREHOLDERS' MANDATE FOR RECURRENT RELATED PARTY TRANSACTIONS ("PROPOSED RENEWAL OF SHAREHOLDERS' MANDATE")
-
Annual Report & CG Report - 2025